Essence and clinical significance of atherosclerosis
Atherosclerosis is a systemic pathological condition rooted in a profound disorder of lipid metabolism. The core of this vascular pathology is that cholesterol (Ch) and its esters begin to deposit abnormally in the inner layer of blood vessels, known as the intima. As a result of this prolonged process, specific structures—atherosclerotic plaques—are formed.
The localization of lesions in atherosclerosis follows clear patterns. The pathological process predominantly affects large- and medium-sized arteries. The primary vascular beds most frequently affected are the aorta, coronary arteries, and cerebral vessels. Atherosclerotic changes are somewhat less commonly registered in the arteries of the lower extremities.
The hemodynamic and pathophysiological consequences of plaque formation result in a significant deterioration of regional blood flow. The narrowing of the arterial lumen leads to tissue hypoperfusion. In clinical practice, these changes inevitably lead to the development of coronary artery disease (CAD), severe cerebrovascular disorders (including strokes), and other serious cardiovascular complications.
Physiological role of major lipids
To deeply understand the pathogenesis of atherosclerosis, it is necessary to examine in detail the physiological role of the main lipids. Three key subjects participate in lipid metabolism, each performing strictly specific functions in the human body:
- Phospholipids (PL): Assume a crucial structural function. They serve as the fundamental basis for the construction of all cell membranes.
- Triglycerides (TG): Act as the main energy substrate. The body uses them as its primary energy source, and excess triglycerides are stored as reserve fat in specialized adipose tissue cells—adipocytes.
- Cholesterol (Ch): Possesses several critically important functions simultaneously. First, it performs a plastic function, actively participating in cell membrane synthesis. Second, it exerts a metabolic (hormonal) function as a basic precursor for the production of steroid hormones. Third, cholesterol has a digestive function: bile acids, which are absolutely essential for adequate emulsification and subsequent absorption of fats from the intestinal lumen, are synthesized directly from it.
The role of the liver in regulating cholesterol metabolism
The central organ that regulates cholesterol metabolism and maintains its strict homeostasis is the liver. Liver cells—hepatocytes—act as the primary storage depot. Cholesterol reserves in this depot are constantly replenished from four main sources:
- Endogenous synthesis: The formation of cholesterol molecules de novo directly within hepatocytes. This is the largest pathway for replenishing reserves, accounting for up to 75% of the total cholesterol pool in the body.
- Alimentary pathway: The intake of exogenous cholesterol via food and its subsequent absorption from the intestine.
- Enterohepatic circulation: The physiological process of the reabsorption of bile acids from the intestine, allowing the body to reuse these compounds.
- Receptor-mediated uptake (plasma transport): The influx of cholesterol from blood plasma. In this case, hepatocytes use specialized receptors to capture circulating lipoproteins containing cholesterol.
Briefly: answers to topical questions
Which lipoprotein classes transport cholesterol in blood plasma?
Cholesterol transport in blood plasma is carried out by several classes of lipoproteins. These include:
- LDL — low-density lipoproteins, which are the main carriers of cholesterol from the liver to peripheral tissues (the atherogenic link).
- HDL — high-density lipoproteins, responsible for the reverse transport of excess cholesterol from tissues to the liver.
- VLDL — very low-density lipoproteins, synthesized by the liver.
- IDL — intermediate-density lipoproteins, formed during VLDL metabolism.
- Chylomicrons — transport exogenous cholesterol from the intestine.
Which enzyme is key in the endogenous synthesis of cholesterol?
The key enzyme in the endogenous synthesis of cholesterol in hepatocytes is HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase). This enzyme catalyzes the early stage of synthesis—the conversion of HMG-CoA to mevalonic acid, from which cholesterol is subsequently formed. Inhibition of this enzyme leads to a reduction in intracellular cholesterol synthesis and serves as the primary biochemical target for statin-class lipid-lowering drugs.
Which hepatocyte receptors are involved in the uptake of cholesterol from blood plasma?
Specific LDL receptors located on hepatocyte membranes are involved in the uptake of cholesterol from blood plasma. They provide receptor-dependent endocytosis of LDL and the uptake of cholesterol from plasma into the cell. When intracellular cholesterol stores are depleted, LDL receptor density increases via a feedback mechanism.
Which groups of lipid-lowering drugs are used to treat atherosclerosis?
Five main groups of lipid-lowering agents, differing in their mechanism of action, are used to treat atherosclerosis:
- Statins — HMG-CoA reductase inhibitors that suppress cholesterol synthesis.
- Cholesterol absorption inhibitors — disrupt sterol absorption in the intestine.
- Bile acid sequestrants — bind bile acids in the intestine, preventing their reabsorption.
- Fibrates — fibric acid derivatives that act as lipoprotein lipase activators.
- Nicotinic acid preparations — triglyceride lipase inhibitors.
Omega-3 fatty acid supplements may also be used in therapy.
How to easily remember the 4 sources of cholesterol in the liver? Use the acronym SAER: Synthesis (endogenous de novo — 75%), Alimentary (from food), Enterohepatic circulation (return of bile acids), Receptor-mediated uptake (from blood plasma).
Class and exam questions
In which vascular layer is cholesterol deposited during atherosclerosis?
Cholesterol and its esters are deposited exclusively in the inner layer of blood vessels—the intima—forming atherosclerotic plaques there.
What is the proportion of endogenous synthesis in the total cholesterol pool?
Endogenous de novo cholesterol synthesis occurs directly in hepatocytes and accounts for the vast majority—up to 75%—of the total cholesterol pool in the body.
Why does the body need normal cholesterol levels?
Cholesterol performs a plastic function (membrane synthesis), a hormonal function (precursor of steroid hormones), and a digestive function (formation of bile acids for fat emulsification).
Which vessels are most frequently affected in atherosclerosis?
Large- and medium-sized arteries are primarily affected. The main vascular beds are the aorta, coronary arteries of the heart, and cerebral vessels.
What else to study on this topic
- Mechanisms of atherosclerotic plaque formation in the vascular intima.
- Pathophysiology of regional blood flow impairment in CAD and strokes.
- Biochemistry of endogenous de novo cholesterol synthesis in hepatocytes.
- The process of fat emulsification and absorption involving bile acids.
- Receptor-mediated uptake of lipoproteins by liver cells.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Pathogenesis of atherosclerosis and the role of lipids" and 5,304 more pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs used for cerebral circulatory disorders"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.